41% OFF

HIV

Taffic Tablet

Original price was: ₹4,388.Current price is: ₹2,600.

You Save ₹1,788 (41%)

Active Composition (per tablet)

Bictegravir 50 mg: Works as an INSTI, blocking HIV integrase and stopping the virus from integrating into host DNA.

Emtricitabine 200 mg: Works as an NRTI, interfering with reverse transcriptase and preventing viral DNA synthesis.

Tenofovir Alafenamide 25 mg: Also an NRTI, helping reduce HIV replication by blocking viral DNA production.

TAFFIC TABLET 30’S is a fixed-dose combination antiretroviral therapy (ART) engineered to deliver a complete, once-daily HIV-1 treatment in a single tablet. Combining the precise actions of Bictegravir, Emtricitabine, and Tenofovir Alafenamide (TAF), this medication represents a modern, streamlined approach to managing HIV-1 infection — targeting the virus through three distinct but complementary mechanisms simultaneously.

Order Online

₹2,600

MRP ₹4,388 — You save 41%

Need a prescription?

Consult our doctor and get one online.

Viropil Tablet Overview

Viropil Tablet, manufactured by Emcure Pharmaceuticals, is a fixed-dose combination antiretroviral medicine containing Dolutegravir 50 mg, Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg. It is prescribed for the long-term treatment of HIV-1 infection in adults and adolescents weighing 35 kg or more, and is also used as Post-Exposure Prophylaxis (PEP) when started within 72 hours of potential HIV exposure and continued for a 28-day course. A valid doctor’s prescription is required.

Quick Facts:

🏭 Manufacturer: Emcure Pharmaceuticals Ltd.
💊 Composition: Dolutegravir 50 mg + Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg
📦 Pack Size: Bottle of 30 tablets
💰 Price: ₹2,900 (MRP ₹4,121 — Save 30%)
✅ Prescription: Required (Schedule H)
🎯 Used For: HIV-1 treatment (ART) & Post-Exposure Prophylaxis (PEP)

⏰ Time-Sensitive PEP Notice: If you have had a potential HIV exposure (unprotected sex, needle-stick injury, condom failure or sexual assault) in the last 72 hours, do not delay. PEP is most effective when started within 2 hours and is no longer effective after 72 hours. Consult our HIV specialist now or call +91 70309 20606.

Uses & Benefits of Viropil Tablet

Common Uses

Taffic Tablet is used for the treatment of HIV-1 infection as part of once-daily antiretroviral therapy.
It helps reduce the viral load in the blood, supporting better long-term HIV treatment outcomes.
Taffic Tablet also helps maintain or improve CD4 cell count, which supports immune system function.
By controlling HIV replication, it may help lower the risk of disease progression and related infections.
When taken regularly as prescribed, Taffic Tablet supports effective and sustained viral suppression.

Key Benefits

Controls HIV Viral Load: Taffic Tablet helps suppress HIV replication and reduce the viral load, supporting effective HIV treatment.
Supports Immunity: By helping maintain healthy CD4 cell count, it supports the immune system and overall HIV management.
Once-Daily Convenience: A single-tablet, once-daily antiretroviral therapy that improves treatment adherence.
Supports Long-Term HIV Control: Regular use of Taffic Tablet helps maintain viral suppression and improve treatment outcomes.

How Viropil Tablet Works

Taffic is a fixed-dose combination antiretroviral that contains:

Bictegravir: An integrase strand transfer inhibitor (INSTI) that blocks viral replication.

Emtricitabine & Tenofovir Alafenamide: Nucleoside reverse transcriptase inhibitors (NRTIs) that prevent HIV from copying itself.

Together, these components help reduce HIV viral load and slow disease progression.

How to Take Viropil Tablet (Dosage)

Take one tablet daily at the same time each day.

Can be taken with or without food.

Do not double the dose to compensate.

Do not miss doses to maintain viral suppression.

For HIV-1 Treatment (ART)

One tablet orally, once daily, with or without food. Treatment is long-term and must be taken consistently as prescribed by an HIV specialist.

For Post-Exposure Prophylaxis (PEP)

Start within 72 hours of potential HIV exposure (the sooner the better).
Take one tablet daily for 28 days.
Swallow whole with a glass of water.
Complete the full 28-day course — do not stop early.

What if I Miss a Dose?

Take the missed dose as soon as you remember.
If it is almost time for the next dose, skip the missed dose.
Do not take two doses at once to make up for a missed one.
If you miss more than one dose during a 28-day PEP course, contact your prescribing doctor immediately.

Safety Advice & Precautions

🍺

Alcohol

CAUTION

Caution is advised when consuming alcohol with Taffic Tablet. Please consult your doctor for guidance.

🤰

Pregnancy

CONSULT YOUR DOCTOR

Taffic Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.

🤱

Breastfeeding

CONSULT YOUR DOCTOR

There is insufficient information on the use of Taffic Tablet while breastfeeding. Please consult your doctor before use.

🚗

Driving

CONSULT YOUR DOCTOR

It is uncertain whether Taffic Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.

🫀

Kidney

CONSULT YOUR DOCTOR

Limited data is available on the safety of Taffic Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.

🫘

Liver

CAUTION

Taffic Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.

Drug Interactions to Inform Your Doctor About

Anti-tuberculosis medicines (rifampicin)
Anti-epileptic medicines (carbamazepine, phenytoin, oxcarbazepine)
Antacids containing magnesium or aluminium
Multivitamins or supplements containing iron or calcium
Herbal products such as St. John’s Wort
Dofetilide (do not co-administer)

Side Effects of Viropil Tablet

⚡ Common Side Effects

Nausea

Diarrhea

Fatigue

Headache

Insomnia

Dizziness

⚠️ Serious – Seek Help Immediately

Liver toxicity (yellowing of skin/eyes, dark urine)

Lactic acidosis (muscle pain, weakness, breathing difficulty)

Severe allergic reactions (rash, swelling, difficulty breathing)

Kidney problems (increased thirst, changes in urination)

Prescription & Doctor Consultation

Viropil Tablet is a Schedule H prescription-only medicine and cannot be sold without a valid prescription from a registered medical practitioner. TAAL+ Healthcare verifies every prescription before dispatch to ensure safe, responsible use.

If you do not have a prescription, you can book a confidential online consultation with our HIV specialist who can assess your case and issue a prescription if appropriate. 👉 Book a consultation now or call +91 70309 20606.

You may also be interested in PrEP for HIV prevention if you are at ongoing risk of HIV exposure, and in HIV testing and viral load monitoring services.

Frequently Asked Questions about Viropil Tablet

Q: What is Taffic Tablet used for?

›

A: Taffic Tablet is used for the treatment of HIV-1 infection as part of antiretroviral therapy. It helps reduce the viral load in the blood and supports long-term HIV management when taken as prescribed.

Q: What is the composition of Taffic Tablet?

›

A: The Taffic tablet composition includes Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg. These three medicines work together to control HIV replication at different stages.

Q: Can Taffic Tablet cure HIV?

›

A: No, Taffic Tablet does not cure HIV-1 infection. It helps control the virus, reduce viral load, and improve treatment outcomes when used regularly as part of long-term HIV treatment.

Q: How should Taffic Tablet be taken?

›

A:Taffic Tablet is usually taken once daily, with or without food, exactly as prescribed by a doctor. It should be taken regularly to maintain effective HIV-1 treatment.

Q: Can Taffic Tablet be taken with other medicines?

›

A:Taffic Tablet may interact with certain other medicines, including some supplements, antibiotics, and antiviral drugs. Always inform your doctor about all medicines you are taking before starting treatment.

Q: Is Taffic Tablet safe during pregnancy or breastfeeding?

›

A:Pregnant or breastfeeding women should take Taffic Tablet only under medical supervision. A doctor will evaluate the benefits and possible risks before prescribing it.

Q: How long do I need to take Taffic Tablet?

›

A:Taffic Tablet is generally used as a long-term treatment for HIV-1 infection. Patients should continue the medicine exactly as prescribed and should not stop treatment without consulting a doctor.

Q: Can I stop taking Taffic Tablet if I feel better?

›

A:No, you should not stop Taffic Tablet without medical advice. Stopping treatment early may increase the risk of viral rebound, treatment failure, or drug resistance.

Manufacturer Information — Emcure Pharmaceuticals

Taffic Tablet is manufactured by Hetero, a well-known pharmaceutical company recognized for producing high-quality antiretroviral medicines used in HIV-1 treatment. Hetero has a strong presence in the healthcare sector and is known for offering reliable therapies that support effective viral suppression and long-term HIV management.

Additional Details

Take Taffic daily to ensure effective HIV suppression.n

Regular HIV viral load and CD4 tests are necessary to monitor treatment effectiveness.

Do not share your medication with others.

Inform your doctor if you have a history of liver or kidney disease.

Customer Reviews

0.0

☆☆☆☆☆

0 reviews

5 ★

4 ★

3 ★

2 ★

1 ★

Please login to write a review.

Medical Disclaimer

The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Viropil Tablet is a prescription-only antiretroviral medicine and must be used under a registered medical practitioner’s supervision. Always consult your doctor before starting, stopping or changing any HIV medication. In case of any adverse reaction, seek immediate medical attention.

Last medically reviewed: May 2026

References: WHO HIV/AIDS Fact Sheet · CDC — PEP Guidance · NACO India

Book a Consultation